Indanorex

Indanorex is a stimulant that was developed in the 1970s for the treatment of obesity. It is chemically related to amphetamine and other psychostimulant drugs.

History

Indanorex was first synthesized in the 1970s as a potential treatment for obesity. It was developed as part of a series of anorectic drugs, which are designed to suppress appetite. However, due to concerns about its potential for abuse and addiction, it was never marketed.

Pharmacology

Indanorex is a norepinephrine-dopamine reuptake inhibitor (NDRI). It works by blocking the reuptake of the neurotransmitters norepinephrine and dopamine, thereby increasing their levels in the brain. This results in increased feelings of satiety and decreased appetite.

Side Effects

Like other stimulant drugs, indanorex can have a number of side effects. These can include insomnia, nervousness, tachycardia (rapid heart rate), and hypertension (high blood pressure). In rare cases, it can also cause psychosis or other serious mental health problems.

Legal Status

Indanorex is currently a controlled substance in many countries, including the United States and the United Kingdom. This means that it is illegal to manufacture, distribute, or possess the drug without a license.

See Also

• Amphetamine
• Anorectic
• Controlled substance
• Obesity

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia